Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq.” J. Can. Res. Updates. 2026;15(1):150-155. doi:10.30683/1929-2279.2026.15.13